guanethidine and labetalol

guanethidine has been researched along with labetalol in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19905 (41.67)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Doggrell, SA; Paton, DM1
Sommers, DK2
Bartsch, W; Böhm, E; Hooper, RG; Sponer, G; Strein, K1
Anderson, RJ; Reed, WG1

Reviews

1 review(s) available for guanethidine and labetalol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

11 other study(ies) available for guanethidine and labetalol

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Effect of labetalol and guanethidine on contractile responses to acetylcholine in the rat anococcygeus muscle.
    The Journal of pharmacy and pharmacology, 1978, Volume: 30, Issue:7

    Topics: Acetylcholine; Animals; Ethanolamines; Guanethidine; Hydroxydopamines; In Vitro Techniques; Labetalol; Male; Muscle Contraction; Phentolamine; Rats

1978
Reactivity of the cardiovascular system in the tetraplegic patient.
    Clinical pharmacology and therapeutics, 1979, Volume: 26, Issue:3

    Topics: Adrenergic beta-Antagonists; Atropine; Blood Pressure; Electrocardiography; Guanethidine; Heart Rate; Hemodynamics; Humans; Labetalol; Male; Nitroglycerin; Phenoxybenzamine; Posture; Propranolol; Quadriplegia; Sympathetic Nervous System; Systole

1979
Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 11

    Topics: Animals; Blood Pressure; Carbazoles; Carvedilol; Disease Models, Animal; Guanethidine; Hypotension, Orthostatic; Labetalol; Prazosin; Propanolamines; Rabbits; Risk; Vasodilator Agents

1987
Current concepts in treatment of hypertensive urgencies.
    American heart journal, 1986, Volume: 111, Issue:1

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Central Nervous System; Clonidine; Diuretics; Ganglia; Guanethidine; Humans; Hypertension; Labetalol; Minoxidil; Patient Compliance; Prazosin; Sympatholytics; Vasodilator Agents

1986
Sympathetic hyperreflexia in tetraplegics. The value of systolic time intervals in assessing drug effects.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1980, Dec-13, Volume: 58, Issue:24

    Topics: Adult; Guanethidine; Humans; Hypertension; Labetalol; Male; Middle Aged; Myocardial Contraction; Phenoxybenzamine; Propranolol; Quadriplegia; Reflex, Abnormal; Systole

1980